Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5692)
All Articles published online
|
Publishing Process of This Article
|
Nov 7, 2013 (publication date) through Dec 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Grasso A, Malfatti F, Testa R. Are metabolic factors still important in the era of direct antiviral agents in patients with chronic hepatitis C? World J Gastroenterol 2013; 19(41): 6947-6956 [PMID: 24222938 DOI: 10.3748/wjg.v19.i41.6947] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i41/6947.htm |
| Number | Citing Articles |
| 1 |
Ayman Alsebaey, Mostafa Elhelbawy, Wael Abdel-Razek, Mohammed Hashim, Hassan Elshenawy, Imam Waked. HCV treatment with direct acting antivirals improves the insulin sensitivity. Expert Review of Anti-infective Therapy 2019; 17(9): 749 doi: 10.1080/14787210.2019.1653184
|
| 2 |
Ayman Alsebaey, Mostafa Elhelbawy, Imam Waked. Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease. European Journal of Gastroenterology & Hepatology 2018; 30(2): 207 doi: 10.1097/MEG.0000000000001013
|
| 3 |
M.A. Shawky, A.Q. Mohammed, A.M. Hassan, B.H. Ali, H.M. Moustafa. Insulin resistance in nondiabetic Egyptian patients with chronic hepatitis C virus. Revista de Gastroenterología de México (English Edition) 2020; 85(2): 173 doi: 10.1016/j.rgmxen.2019.05.007
|
| 4 |
Adauto CASTELO, Carlos Eduardo BRANDÃO MELLO, Rosangela TEIXEIRA, Jose Valdez Ramalho MADRUGA, Tania REUTER, Leila Maria Moreira Beltrão PEREIRA, Giovanni Faria SILVA, Mario Reis ÁLVARES-DA-SILVA, Heverton ZAMBRINI, Paulo Roberto Abrão FERREIRA. HEPATITIS C IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM: BURDEN OF DISEASE. Arquivos de Gastroenterologia 2018; 55(4): 329 doi: 10.1590/s0004-2803.201800000-74
|
| 5 |
Vincenzo Boccaccio, Savino Bruno. Optimal management of patients with chronic hepatitis C and comorbidities. Liver International 2015; 35(s1): 35 doi: 10.1111/liv.12712
|
| 6 |
Ghada El Sagheer, Elwy Soliman, Asmaa Ahmad, Lamiaa Hamdy. Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs. Libyan Journal of Medicine 2018; 13(1): 1435124 doi: 10.1080/19932820.2018.1435124
|
| 7 |
Mostafa Elhelbawy, Wael Abdel-Razek, Ayman Alsebaey, Mohamed Hashim, Hassan Elshenawy, Imam Waked. Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment. European Journal of Gastroenterology & Hepatology 2019; 31(1): 16 doi: 10.1097/MEG.0000000000001215
|
| 8 |
M.A. Shawky, A.Q. Mohammed, A.M. Hassan, B.H. Ali, H.M. Moustafa. Resistencia a la insulina en pacientes egipcios no diabéticos infectados con el virus de hepatitis C crónica. Revista de Gastroenterología de México 2020; 85(2): 173 doi: 10.1016/j.rgmx.2019.05.005
|
| 9 |
Ludovico Abenavoli, Mario Masarone, Valentina Peta, Natasa Milic, Nazarii Kobyliak, Samir Rouabhia, Marcello Persico. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3. World Journal of Gastroenterology 2014; 20(41): 15233-15240 doi: 10.3748/wjg.v20.i41.15233
|
| 10 |
Shira Yair-Sabag, Elchanan Nussinson, Ofir Ben-Assuli, Fahmi Shibli, Azmi Shahbari, Shira Zelber-Sagi. Retrospective study of the associations between hepatitis C virus infection and metabolic factors. World Journal of Hepatology 2016; 8(30): 1269-1278 doi: 10.4254/wjh.v8.i30.1269
|
| 11 |
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona, Giovanni Targher. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World Journal of Gastroenterology 2016; 22(44): 9674-9693 doi: 10.3748/wjg.v22.i44.9674
|